Cellular Origins acquires Actia Platform IP to enhance automated cell therapy manufacturing Jul 2, 2024
Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability May 16, 2024